Editorial Comment to High neutrophil-to-lymphocyte ratio predicts poor clinical outcome in patients with castration-resistant prostate cancer treated with docetaxel chemotherapy

Robert Soest

doi:10.1111/iju.12856

Editorial Comment to High neutrophil-to-lymphocyte ratio predicts poor clinical outcome in patients with castration-resistant prostate cancer treated with docetaxel chemotherapy

Robert Soest

Urology

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	834-834
Number of pages	1
Journal	International Journal of Urology
Volume	22
Issue number	9
DOIs	https://doi.org/10.1111/iju.12856
Publication status	Published - 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Research programs

EMC MM-03-49-01

Access to Document

10.1111/iju.12856

http://hdl.handle.net/1765/90311

Cite this

@article{548d332b22574eac9501b91e8e70ad68,

title = "Editorial Comment to High neutrophil-to-lymphocyte ratio predicts poor clinical outcome in patients with castration-resistant prostate cancer treated with docetaxel chemotherapy",

author = "Robert Soest",

year = "2015",

doi = "10.1111/iju.12856",

language = "Undefined/Unknown",

volume = "22",

pages = "834--834",

journal = "International Journal of Urology",

issn = "0919-8172",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "9",

}

TY - JOUR

T1 - Editorial Comment to High neutrophil-to-lymphocyte ratio predicts poor clinical outcome in patients with castration-resistant prostate cancer treated with docetaxel chemotherapy

AU - Soest, Robert

PY - 2015

Y1 - 2015

U2 - 10.1111/iju.12856

DO - 10.1111/iju.12856

M3 - Article

C2 - 26104026

SN - 0919-8172

VL - 22

SP - 834

EP - 834

JO - International Journal of Urology

JF - International Journal of Urology

IS - 9

ER -